Groupe Athena Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,072.20
7,824.80
9,340.80
10,564.80
13,418.50
17,456.80
Total Accounts Receivable
5,184.50
1,211.00
1,200.30
1,220.70
1,007.30
1,080.30
Inventories
29.50
30.10
30.30
32.00
32.20
32.60
Other Current Assets
0.90
5,922.60
8,621.20
9,229.70
11,736.00
13,873.60
Total Current Assets
10,287.20
14,988.50
19,192.60
21,047.10
26,194.00
32,443.30
Net Property, Plant & Equipment
5,461.50
2,967.70
1,170.20
153.80
710.60
613.80
Total Investments and Advances
25.00
25.00
25.00
25.00
25.00
25
Intangible Assets
-
4,269.20
6,480.50
12,096.50
9,662.90
9,901.70
Total Assets
15,773.70
22,250.30
26,868.40
33,322.50
36,592.50
42,983.70
Accounts Payable
2.10
3.80
3.80
3.80
3.90
Other Current Liabilities
76.50
49.90
54.60
57.30
55.90
Total Current Liabilities
78.70
53.70
58.40
61.10
59.80
Total Liabilities
78.70
53.70
58.40
61.10
59.80
Common Equity (Total)
15,695.00
22,196.60
26,810.00
33,261.40
36,532.70
Total Shareholders' Equity
15,695.00
22,196.60
26,810.00
33,261.40
36,532.70
Total Equity
15,695.00
22,196.60
26,810.00
33,261.40
36,532.70
Liabilities & Shareholders' Equity
15,773.70
22,250.30
26,868.40
33,322.50
36,592.50

About Groupe Athena

View Profile
Address
10/234 Dadisheth Agiary Lane
Mumbai Maharashtra 400002
India
Employees -
Website http://www.groupeathena.com
Updated 07/08/2019
Groupe Athena, Inc. engages in the provision of pharmaceutical research and testing services. It is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the U. S.